eXmoor pharma’s manufacturing facility receives licence from MHRA
The company’s Cell & Gene Therapy Centre can now offer a full range of GMP services Press release: eXmoor pharma,...
adminph
Pfizer and BioNTech provide update on mRNA-based combination vaccine program against influenza and COVID-19 in individuals 18-64 years of age
Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced top-line results from their Phase 3 clinical trial...
Oncimmune announces new contract with global pharma company
The contract concerns profiling Immunoglobulin E autoantibodies in blood serum Oncimmune, an autoantibody profiling company providing research services to the...
Nature publishes new research on genetic causes of colorectal cancer
In the UK study, researchers analysed 2,023 bowel cancers from the 100,000 Genomes Project Colorectal cancer (CRC) is the third...
Researchers make breakthrough in fight against COVID-19
A team led by Jose Onuchic at Rice University and Paul Whitford at Northeastern University, both researchers at the National...
Researchers map interactions of 144 active substances to identify drug benefits
The study yielded over one million dose-responsive curves for existing cancer drugs Researchers from the Technical University of Munich (TUM)...
New research reveals AI bowel cancer test can help patients avoid chemotherapy
This form of cancer was responsible for 1.9 million diagnosed cases worldwide in 2020 A study led by researchers at...
New AI tool captures how proteins behave in context
A fish on land still waves its fins, but the results are markedly different when that fish is in water....
Study identifies new disease-inducing mechanism for inflammatory bowel disease
Combined, Crohn’s disease and ulcerative colitis affect over 500,000 people in the UK Researchers from Newcastle University, Great North Children’s...
McMaster drug trial receives more than $6m to test smallpox vaccine against mpox
Children accounted for the majority of mpox cases and deaths in the DRC since June 2023 Researchers from McMaster University...
FDA approves first nasal spray for treatment of anaphylaxis
The U.S. Food and Drug Administration approved neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I),...
Study finds AI reduces underdiagnosis of Black patients with common heart failure
Heart failure with preserved ejection fraction makes up 50% of all UK heart failure cases A study led by King’s...
International researchers use shear waves to map blood vessel structures
The findings could improve cancer treatment and drug delivery to treat tumours Researchers from King’s College London’s (KCL) School of...
An appetizer can stimulate immune cells' appetite, a boon for cancer treatments
The body has a veritable army constantly on guard to keep us safe from microscopic threats from infections to cancer....
Francis Crick scientists reveal how cells ‘raise the alarm’ when damaged or infected
The V-ATPase protein, V1H, was found to be involved in the process of raising the alarm Scientists at the Francis...
CMT Research Foundation invests in research project to develop treatments for CMTs
The rare, peripheral neuropathy disease affects nearly three million people globally The CMT Research Foundation (CMTRF) has invested in a...
NK cells expressing interleukin-21 show promising antitumor activity in glioblastoma cells
Natural killer (NK) cells engineered to express interleukin-21 (IL-21) demonstrated sustained antitumor activity against glioblastoma stem cell-like cells (GSCs) both...
UCL study reveals routine blood tests could improve early cancer diagnosis
Bowel cancer was the most common cancer to be identified in both men and women Researchers from University College London...
Study suggests COVID-19 vaccination lowers incidence of arterial thromboses
A second dose of the vaccine lowered the incidence of conditions such as heart attack or stroke Researchers from the...
Pfizer announces top-line results of ABRYSVO® for RSV in immunocompromised adults
Pfizer Inc. (NYSE: PFE) today announced positive top-line safety and immunogenicity results from substudy B of the ongoing pivotal Phase...
